Trial intelligence / Profile preview

IMPACT: Clopidogrel Loading Dose in Carotid Artery Stenting

NCT01146301Phase 4Completed

Sponsor
R&D Cardiologie
Start
Mar 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of clopidogrel in carotid artery stenosis (2 arms), sponsored by R&D Cardiologie. Primary endpoints: Number of TCD-detected microemboli and Absolute level of platelet inhibition. Started Mar 2008; status: completed.

02

Drugs

clopidogrel
03

Conditions

carotid artery stenosis

Beyond the preview

Go deeper on NCT01146301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01146301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call